Article Details

Stopping Mutant KRAS Could Lead to Enhanced Therapies for Pancreatic Cancer

Retrieved on: 2021-03-10 19:30:00

Tags for this article:

Click the tags to see associated articles and topics

Stopping Mutant KRAS Could Lead to Enhanced Therapies for Pancreatic Cancer. View article details on hiswai:

Excerpt

However, they fail to evade the immune system in immunocompetent wild-type mice, triggering a strong antitumor response. “The key insight of the ...

Article found on: news.stonybrook.edu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up